financetom
Business
financetom
/
Business
/
UK set to announce 'root and branch' reform of broken water industry
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UK set to announce 'root and branch' reform of broken water industry
Jul 20, 2025 2:50 PM

LONDON, July 20 (Reuters) - Britain announced on Sunday

it would create an ombudsman to oversee its broken water sector

ahead of a major review which is expected to recommend a reset

of how the industry is structured and regulated.

After winning power last year, the Labour government ordered

an examination of the privatised water industry in England and

Wales, which needs huge investments to fix aging infrastructure

and stem record sewage spills into rivers and lakes that have

angered the public.

Former Bank of England deputy governor Jon Cunliffe, who has

led the review, is due to publish his findings on Monday.

Indications are that he will suggest scrapping Ofwat, the water

industry's financial regulator.

Ahead of the publication, the government said it would set

up a water ombudsman with legal powers to help customers dealing

with leaking pipes, incorrect bills or supply problems.

"The water industry is broken," environment minister Steve

Reed is expected to say in a speech on Monday, according to his

office.

"Today's final report from Sir Jon Cunliffe's Independent

Water Commission offers solutions to fix our broken regulatory

system so the failures of the past can never happen again."

In an interim report in June, Cunliffe recommended

overhauling regulation to lower investment risk, merging

regulators to give companies clearer direction and new rules on

river bathing standards.

His final report comes as Thames Water, the country's

biggest water company which is facing 1.4 billion pounds ($1.9

billion) in pollution fines and penalties over the next five

years, teeters on the brink of failure with the possibility the

government might have to step in.

In his speech, Reed, who promised on Sunday to halve sewage

pollution by 2030, was expected to announce "root and branch"

reform of the sector's regulation, his office said.

"We are establishing a new partnership where water

companies, investors, communities and the government will work

together to clean up our rivers, lakes and seas for good," he

was expected to say.

($1 = 0.7460 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Neurocrine Biosciences Says Late-Stage Movement Disorder Study Shows Ingrezza's Therapeutic Efficacy at Lowest Available Dose
Neurocrine Biosciences Says Late-Stage Movement Disorder Study Shows Ingrezza's Therapeutic Efficacy at Lowest Available Dose
Oct 17, 2025
09:29 AM EDT, 10/17/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Friday that a new post-hoc analysis of a late-stage study showed clinically meaningful improvements in tardive dyskinesia symptoms in patients treated with Ingrezza at the lowest available dose of 40 mg. The company said 90% of participants who received continuous treatment for 48 weeks improved by at...
Form 8.3 - Spectris plc
Form 8.3 - Spectris plc
Oct 17, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
AbbVie Closes Bretisilocin Acquisition
AbbVie Closes Bretisilocin Acquisition
Oct 17, 2025
09:28 AM EDT, 10/17/2025 (MT Newswires) -- AbbVie ( ABBV ) said Friday it has closed the acquisition of Gilgamesh Pharmaceuticals' lead investigational candidate bretisilocin. Bretisilocin is a psychedelic compound in phase 2 clinical development for the treatment of patients with moderate to severe major depressive disorder, AbbVie ( ABBV ) said. ...
Visionary Completes Controlling Stake in Sikang Health Industry Joint Venture Platform, Deepening Global Layout of TCM Health Preservation
Visionary Completes Controlling Stake in Sikang Health Industry Joint Venture Platform, Deepening Global Layout of TCM Health Preservation
Oct 17, 2025
TORONTO, Oct. 17, 2025 /PRNewswire/ -- Visionary Holdings Inc. ( GV ) , a Nasdaq-listed enterprise, announced today that it has completed the equity adjustment of Sikang (Guangzhou) Health Industry Investment Co., Ltd. (hereinafter referred to as the Joint Venture Company), a joint venture established with Guangzhou Sikang Investment Holding Co., Ltd. (hereinafter referred to as Guangzhou Sikang), and officially...
Copyright 2023-2026 - www.financetom.com All Rights Reserved